Table 1 Patients’ demographics and perioperative outcomes
Variables | n = 59 |
|---|---|
Age [y.o.], median (range) | 65.0 (51–74) |
Body weight [kg], median (range) | 65 (50.0–92.2) |
Body mass index [kg/m2], median (range) | 23.0 (18.9–30.9) |
Prostate volume [cm3], median (range) | 24.0 (15.0–57.0) |
Serum PSA [ng/dl], median (range) | 8.0 (2.8–33.0) |
Biopsy Gleason score, n (%) | |
6 or less | 8 (13.6) |
7 | 30 (50.8) |
8 or higher | 21 (35.6) |
clinical T stage, n (%) | |
T1c | 35 (59.3) |
T2a | 8 (13.6) |
T2b | 3 (5.1) |
T2c | 2 (3.4) |
T3 | 1 (1.7) |
Unknown | 10 (16.9) |
Operation time [min], median (range) | 265 (129–487) |
Console time [min], median (range) | 207 (88–429) |
Nerve-sparing, n (%) | |
Unilateral | 11 (18.6) |
Bilateral | 2 (3.4) |
None | 46 (80.0) |
Intraoperative blood loss, median (range) | 275 (0–1650) |